1. Stinson SC (2001) Chiral chemistry. Chem Eng News 79:45–56
2. Food and Drug Administration [FDA] (1992) FDA’s policy statement for the development of new stereoisomeric drugs. US Food and Drug Administration [policy document] http://www.fda.gov/cder/guidance/stereo.htm . Fed Reg.22:249. Accessed June 16 2009
3. Agranat I, Caner H (2002) Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 1:753–768
4. Howland RH (2009) Clinical implications of chirality and stereochemistry in psychopharmacology. J Psychosoc Nurs Ment Health Serv 47:17–21
5. Patil PA, Kothekar MA (2006) Development of safer molecules through chirality. Indian J Med Sci 60:427–437